Tokyo, April 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061371) titled 'Triptans and lasmiditan in patients with migraine attacks associated with neurodevelopmental disorders' on April 24.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - University of Tsukuba, Mito Medical Center, Mito Kyodo General Hospital
Condition:
Condition - patients with migraine attacks accompanied by neurodevelopmental disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Triptans and lasmiditan are considered specific ...